Reference
Babai S, et al. Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study. Drug Safety : 19 Oct 2019. Available from: URL: https://doi.org/10.1007/s40264-019-00875-6
Rights and permissions
About this article
Cite this article
Immune checkpoint inhibitor-induced vitiligo. Reactions Weekly 1777, 8 (2019). https://doi.org/10.1007/s40278-019-70593-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-70593-6